T 0489/13 of 06.09.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T048913.20160906
- Date of decision
- 6 September 2016
- Case number
- T 0489/13
- Online on
- 11 April 2017
- Petition for review of
- -
- Application number
- 06707141.5
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL COMPOSITION COMPRISING AN OMEGA-CARBOXYARYL SUBSTITUTED DIPHENYL UREA FOR THE TREATMENT OF CANCER
- Applicant name
- Bayer HealthCare LLC
- Opponent name
- Altmann, Andreas
Teva Pharmaceutical Industries Ltd. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12Rules of procedure of the Boards of Appeal Art 13European Patent Convention Art 111(1)
- Keywords
- Novelty - main request (yes)
Inventive step - main request (no)
Late-filed evidence - admitted (no)
Auxiliary request 1 - admitted (yes)
Remittal (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.